Reynolds J C
Div. of Gastroenterology and Hepatology, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.
Scand J Gastroenterol Suppl. 1995;213:17-24.
Although gastroesophageal reflux disease is among the most common disorders seen by gastroenterologists, the wide variation in both its symptoms and severity has led to a lack of consensus about the most appropriate practical approach to treatment of patients with acute symptoms. This review considers the efficacy of the most widely used pharmacologic agents in the acute treatment of gastroesophageal reflux disease: H2-receptor antagonists, proton-pump inhibitors, and prokinetic agents. Possible treatment strategies in which they may be used are discussed and it is proposed that individualized treatment strategies should be developed based on symptoms and severity of disease. Emphasis is placed on the fact that, given the wide variety of effective agents available, the use of the same agent in every patient, regardless of their symptoms, is a most inappropriate approach. A stepwise approach to therapy utilizing a number of drug classes is discussed and the rationale for and appropriate use of both a 'step-up' and 'step-down' approach is considered.
尽管胃食管反流病是胃肠病学家诊治的最常见疾病之一,但其症状和严重程度差异很大,导致在如何以最恰当的实际方法治疗急性症状患者方面缺乏共识。本综述探讨了最广泛使用的药物制剂在胃食管反流病急性治疗中的疗效:H2受体拮抗剂、质子泵抑制剂和促动力药。文中讨论了可能使用这些药物的治疗策略,并建议应根据症状和疾病严重程度制定个体化治疗策略。重点强调了这样一个事实,鉴于有多种有效药物可供选择,对每个患者都使用同一种药物,而不考虑其症状,是极不恰当的做法。文中讨论了采用多种药物类别的逐步治疗方法,并考虑了“逐步升级”和“逐步降级”方法的原理及合理应用。